ENTITY

AIM ImmunoTech (AIM US)

1
Analysis
Health Care • United States
AIM ImmunoTech Inc. is an immuno-pharma company. The Company focuses onthe research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders. AIM ImmunoTech operates in the United States.
more
Exchange Announcement • 01 Oct 2026 04:07

Annual Report to Security Holders (Form ARS | Period ending 2025-12-31)

Exchange Announcement • 15 Sep 2026 04:35

Current Report (Form 8-K | Period ending 2026-09-08)

Exchange Announcement • 11 Sep 2026 04:35

Current Report (Form 8-K | Period ending 2026-09-03)

Exchange Announcement • 05 Sep 2026 04:05

Current Report (Form 8-K | Period ending 2026-08-31)

Exchange Announcement • 11 Aug 2026 20:40

Current Report (Form 8-K | Period ending 2026-08-11)

x